The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GastroPET: Phase II academic clinical trial evaluating sequential FDG-PET driven preoperative treatment strategy in locally advanced oesophago-gastric cancer in the context of miRNA- and immune-based biomarkers.
 
Radka Obermannova
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck KGaA
Speakers' Bureau - Amgen; Bristol-Myers Squibb; SERVIER
 
Renata Hejnova
No Relationships to Disclose
 
Lenka Zdrazilova-Dubska
No Relationships to Disclose
 
Regina Demlova
No Relationships to Disclose
 
Ondrej Slaby
No Relationships to Disclose
 
Hana Studentova
No Relationships to Disclose
 
Lubos Petruzelka
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Roche
 
Peter Grell
No Relationships to Disclose
 
Rostislav Vyzula
Consulting or Advisory Role - Roche